Patient-reported outcome measures: the importance of patient satisfaction in surgery
In recent years, much attention has been paid to the assessment of the quality of health care.
This focus has been driven mainly by a desire to improve health care and decrease …
This focus has been driven mainly by a desire to improve health care and decrease …
[HTML][HTML] Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal …
Background The endoscopic radiofrequency procedure (Stretta) has been used for more
than a decade to treat patients with gastroesophageal reflux disease (GERD). However, the …
than a decade to treat patients with gastroesophageal reflux disease (GERD). However, the …
Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the …
P Salminen, S Grönroos, M Helmiö, S Hurme… - JAMA …, 2022 - jamanetwork.com
Importance Long-term results from randomized clinical trials comparing laparoscopic sleeve
gastrectomy (LSG) with laparoscopic Roux-en-Y-gastric bypass (LRYGB) are limited …
gastrectomy (LSG) with laparoscopic Roux-en-Y-gastric bypass (LRYGB) are limited …
Randomized trial of medical versus surgical treatment for refractory heartburn
SJ Spechler, JG Hunter, KM Jones, R Lee… - … England Journal of …, 2019 - Mass Medical Soc
Background Heartburn that persists despite proton-pump inhibitor (PPI) treatment is a
frequent clinical problem with multiple potential causes. Treatments for PPI-refractory …
frequent clinical problem with multiple potential causes. Treatments for PPI-refractory …
Association of acute gastroesophageal reflux disease with esophageal histologic changes
KB Dunbar, AT Agoston, RD Odze, X Huo, TH Pham… - Jama, 2016 - jamanetwork.com
Importance The histologic changes associated with acute gastroesophageal reflux disease
(GERD) have not been studied prospectively in humans. Recent studies in animals have …
(GERD) have not been studied prospectively in humans. Recent studies in animals have …
[HTML][HTML] Outcomes after a decade of laparoscopic giant paraesophageal hernia repair
JD Luketich, KS Nason, NA Christie… - The Journal of thoracic …, 2010 - Elsevier
OBJECTIVE: Laparoscopic repair of giant paraesophageal hernia is a complex operation
requiring significant laparoscopic expertise. Our objective was to compare our current …
requiring significant laparoscopic expertise. Our objective was to compare our current …
Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs)
RC Macefield, M Jacobs, IJ Korfage, J Nicklin… - Trials, 2014 - Springer
Background Synthesis of patient-reported outcome (PRO) data is hindered by the range of
available PRO measures (PROMs) composed of multiple scales and single items with …
available PRO measures (PROMs) composed of multiple scales and single items with …
Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study
H Inoue, M Tanabe, ER de Santiago… - Endoscopy …, 2020 - thieme-connect.com
Background The incidence of proton pump inhibitor (PPI)-refractory gastroesophageal reflux
disease (GERD) has been increasing. While surgical intervention with Laparoscopic Nissen …
disease (GERD) has been increasing. While surgical intervention with Laparoscopic Nissen …
Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one-and 2-year results of a feasibility trial
L Bonavina, T DeMeester, P Fockens, D Dunn… - Annals of …, 2010 - journals.lww.com
Objectives: One-and 2-year evaluation of a feasibility trial (clinicaltrials. gov registration
numbers NCT01057992, NCT01058070, and 01058564) to assess the safety and efficacy of …
numbers NCT01057992, NCT01058070, and 01058564) to assess the safety and efficacy of …
[HTML][HTML] Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
KN Lee, OY Lee, HJ Chun, JI Kim, SK Kim… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Fexuprazan, a novel potassium-competitive acid blocker, reversibly
suppresses the K+/H+-ATPase enzyme in proton pumps within gastric parietal cells …
suppresses the K+/H+-ATPase enzyme in proton pumps within gastric parietal cells …